NanoViricides (NNVC) Stock Chart & Stock Price History $1.31 +0.05 (+3.97%) As of 05/15/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock NanoViricides Stock Price Performance The NanoViricides (NNVC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 41.26%, with a year-to-date return of -8.39%. In the past month, the stock has decreased 6.43%, reflecting recent market activity. As of the latest close, NanoViricides traded at $1.31 with a market cap of $20.49 million and volume of 57,114 shares. Receive NNVC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NanoViricides and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.76%1 Month Performance-6.43%3 Month Performance-2.96%Year-To-Date Performance-8.39%1 Year Performance-41.26% NNVC Stock Chart for Friday, May, 16, 2025 NNVC Chart by TradingView NanoViricides Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/15/2025$1.26$1.31+3.97%$1.31$1.2657,114 shs$20.49 million05/14/2025$1.25$1.26+0.80%$1.34$1.2448,374 shs$19.71 million05/13/2025$1.28$1.25-2.42%$1.31$1.2559,892 shs$19.55 million05/12/2025$1.32$1.28-2.95%$1.32$1.2572,153 shs$20.04 million05/09/2025$1.41$1.32-6.38%$1.44$1.28118,881 shs$20.65 million05/08/2025$1.24$1.41+14.17%$1.45$1.26385,585 shs$22.05 million05/07/2025$1.31$1.24-5.73%$1.29$1.2059,128 shs$19.32 million05/06/2025$1.25$1.31+4.59%$1.28$1.2514,729 shs$20.49 million05/05/2025$1.30$1.25-3.65%$1.33$1.2538,368 shs$19.59 million05/02/2025$1.33$1.30-2.26%$1.37$1.2785,979 shs$20.33 million Get the Latest News and Ratings for NNVC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NanoViricides and its competitors with MarketBeat's FREE daily newsletter. 05/01/2025$1.37$1.33-2.92%$1.40$1.3082,360 shs$20.80 million04/30/2025$1.34$1.37+2.24%$1.42$1.3594,941 shs$21.43 million04/29/2025$1.35$1.34-0.37%$1.36$1.3139,792 shs$20.96 million04/28/2025$1.42$1.35-5.28%$1.42$1.3259,549 shs$21.04 million04/25/2025$1.35$1.42+5.19%$1.42$1.37113,018 shs$22.21 million04/24/2025$1.33$1.35+1.20%$1.37$1.3339,972 shs$21.12 million04/23/2025$1.34$1.33-0.45%$1.39$1.3051,902 shs$20.87 million04/22/2025$1.30$1.34+3.08%$1.37$1.3040,149 shs$20.96 million04/21/2025$1.33$1.30-2.26%$1.38$1.30104,566 shs$20.33 million04/18/2025$1.33$1.33$1.35$1.25106,855 shs$20.80 million04/17/2025$1.40$1.33-5.00%$1.35$1.25106,855 shs$20.80 million04/16/2025$1.33$1.40+5.26%$1.48$1.34325,322 shs$21.90 million04/15/2025$1.19$1.33+11.76%$1.33$1.15181,255 shs$20.80 million Related Companies Adagene Stock Price Chart CervoMed Stock Price Chart TScan Therapeutics Stock Price Chart I-Mab Stock Price Chart Maxpro Capital Acquisition Stock Price Chart Inozyme Pharma Stock Price Chart Caribou Biosciences Stock Price Chart Adaptimmune Therapeutics Stock Price Chart Genenta Science Stock Price Chart Exicure Stock Price Chart Receive NNVC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NanoViricides and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:NNVC) was last updated on 5/16/2025 by MarketBeat.com Staff From Our PartnersTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Big Swings in Crypto Right Now — and Bigger Moves Could Be Coming That kind of whiplash might scare some fo...Crypto 101 Media | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredCan This System Really Predict Stocks to the Day?Imagine foreseeing a 30% stock jump — to the day — weeks before it happens. Introducing a new way to predict t...InvestorPlace | SponsoredTrump Made a Deal. Your Retirement Could Still Be in Danger.America is still barreling toward a financial cliff. This isn't political. It's mathematical. And no trade ...Lear Capital | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NanoViricides, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NanoViricides With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.